Leadership Overview
Pierre Fabre has 8 executives leading key functions including strategy, financial oversight, operational management, dermo-cosmetics development, and human resources.
Focused on advancing global health and beauty standards, Pierre Fabre delivers innovative pharmaceutical solutions and dermo-cosmetic products while maintaining a commitment to scientific excellence and sustainable market growth across international territories.
Focused on advancing global health and beauty standards, Pierre Fabre delivers innovative pharmaceutical solutions and dermo-cosmetic products while maintaining a commitment to scientific excellence and sustainable market growth across international territories.
Leadership Roles at Pierre Fabre
Seokhwan Cho - Chief Executive Officer
Seokhwan Cho, the Chief Executive Officer at Pierre Fabre, directs the overarching strategic vision for the pharmaceutical and dermo-cosmetic divisions. By aligning corporate objectives with global market demands, the Chief Executive Officer ensures consistent growth across the European and Asian sectors. This leadership role involves managing complex cross-functional teams to optimize drug development pipelines and consumer health care initiatives. Seokhwan Cho maintains rigorous standards for operational efficiency, driving the company toward long-term profitability and scientific innovation. Through constant collaboration with the board, the Chief Executive Officer shapes the future trajectory of the organization. By prioritizing research-driven solutions, the Chief Executive Officer secures a competitive advantage in the global marketplace. Ultimately, the Chief Executive Officer fosters a culture of excellence that permeates every level of the enterprise, ensuring that the company remains a leader in the pharmaceutical industry while delivering high-quality products to patients and consumers worldwide.
Venaig Solinhac - Chief Executive Officer, Dermo-Cosmetics & Personal Care division
Venaig Solinhac, the Chief Executive Officer, Dermo-Cosmetics & Personal Care division at Pierre Fabre, leads the strategic development and market expansion of the dermo-cosmetic portfolio. Overseeing the growth of brands like Eau Thermale Avène, the Chief Executive Officer, Dermo-Cosmetics & Personal Care division ensures that product innovation meets the evolving needs of global consumers. This role involves managing the entire lifecycle of dermo-cosmetic products, from research and development to international distribution. Venaig Solinhac directs marketing strategies that emphasize the scientific heritage and quality of the brand. By fostering partnerships with dermatologists and health professionals, the Chief Executive Officer, Dermo-Cosmetics & Personal Care division strengthens the market position of the company. The Chief Executive Officer, Dermo-Cosmetics & Personal Care division coordinates with manufacturing teams to ensure that production capacity meets global demand. Through a focus on consumer-centric innovation, the Chief Executive Officer, Dermo-Cosmetics & Personal Care division drives revenue growth and brand loyalty. Ultimately, the Chief Executive Officer, Dermo-Cosmetics & Personal Care division maintains the leadership status of the company in the competitive dermo-cosmetic sector.

Ewart Toit - Chief Financial Officer
Ewart Toit, the Chief Financial Officer at Pierre Fabre, manages the fiscal health and capital allocation strategies for the entire organization. Overseeing global financial reporting, the Chief Financial Officer ensures transparency and compliance across all international operations. This role involves analyzing market trends to support investment decisions in the pharmaceutical and dermo-cosmetic sectors. Ewart Toit directs the budgeting process, providing the necessary resources for research and development initiatives. By monitoring cash flow and risk management, the Chief Financial Officer maintains the financial stability required for sustained expansion. The Chief Financial Officer collaborates with executive leadership to evaluate potential acquisitions and partnerships that align with the company mission. Through precise financial modeling, the Chief Financial Officer optimizes resource distribution to maximize shareholder value. Ultimately, the Chief Financial Officer provides the fiscal foundation that enables the company to pursue ambitious growth targets while navigating the complexities of the global pharmaceutical landscape.
Amanda de Lima Ventura - Chief Financial Officer (Brazil)
Amanda de Lima Ventura, the Chief Financial Officer (Brazil) at Pierre Fabre, manages the financial operations and economic strategy within the South American market. Overseeing regional fiscal performance, the Chief Financial Officer (Brazil) ensures that local business units maintain profitability while adhering to corporate standards. This role involves navigating complex regulatory environments and currency fluctuations to protect the financial interests of the company. Amanda de Lima Ventura directs the allocation of capital for regional marketing and distribution efforts, particularly for the dermo-cosmetic portfolio. By analyzing local market data, the Chief Financial Officer (Brazil) provides actionable insights that inform broader corporate strategy. The Chief Financial Officer (Brazil) collaborates with regional leadership to optimize supply chain costs and improve operational margins. Through diligent financial oversight, the Chief Financial Officer (Brazil) supports the expansion of the brand presence in the region. Ultimately, the Chief Financial Officer (Brazil) secures the financial health of the Brazilian operations, contributing significantly to the global success of the organization.
Marcela Pacobahyba - Chief of Staff
Marcela Pacobahyba, the Chief of Staff at Pierre Fabre, coordinates strategic initiatives and facilitates communication between the executive leadership team and various departments. Overseeing the execution of corporate priorities, the Chief of Staff ensures that organizational goals remain aligned with the broader mission of the company. This role involves managing high-level projects that span both the pharmaceutical and dermo-cosmetic divisions. Marcela Pacobahyba optimizes internal processes to improve operational efficiency and cross-departmental collaboration. By acting as a central point of contact for the executive office, the Chief of Staff streamlines decision-making and enhances the flow of critical information. The Chief of Staff supports the development of long-term strategies by providing data-driven insights and administrative oversight. Through meticulous planning and coordination, the Chief of Staff enables the leadership team to focus on core business objectives. Ultimately, the Chief of Staff drives organizational cohesion and ensures that the company maintains its focus on delivering high-quality health and beauty solutions.
Paulo Ferraz - Country Chief Finance Officer
Paulo Ferraz, the Country Chief Finance Officer at Pierre Fabre, manages the financial operations and reporting for specific national markets. Overseeing local budget execution, the Country Chief Finance Officer ensures that regional business units operate within the established financial framework. This role involves monitoring local market conditions and adjusting financial strategies to mitigate risks. Paulo Ferraz directs the preparation of financial statements and ensures compliance with local tax laws and corporate reporting standards. By providing accurate financial data to the executive team, the Country Chief Finance Officer supports informed decision-making at the regional level. The Country Chief Finance Officer collaborates with local sales and marketing teams to optimize the profitability of product launches. Through rigorous cost control measures, the Country Chief Finance Officer improves the operational efficiency of the national branch. Ultimately, the Country Chief Finance Officer secures the financial integrity of the regional operations, contributing to the overall stability and growth of the company in the international market.
Kamel Khlifati - Drh
Kamel Khlifati, the Drh at Pierre Fabre, manages human capital strategies and organizational development for the pharmaceutical division. Overseeing talent acquisition and employee engagement, the Drh ensures that the workforce possesses the necessary skills to support scientific innovation. This role involves designing training programs that align with the technical requirements of drug manufacturing and research. Kamel Khlifati directs performance management systems to foster a culture of accountability and professional growth. By implementing policies that promote diversity and inclusion, the Drh strengthens the organizational culture. The Drh collaborates with department heads to identify staffing needs and optimize team structures for maximum efficiency. Through strategic workforce planning, the Drh supports the long-term objectives of the company. By addressing the evolving needs of the employees, the Drh maintains high levels of retention and productivity. Ultimately, the Drh builds a robust organizational foundation that enables the company to excel in the highly competitive pharmaceutical industry while attracting top-tier talent from across the globe.
Yann Dugenou - Drh
Yann Dugenou, the Drh at Pierre Fabre, leads human resources initiatives focused on the dermo-cosmetics division and corporate support functions. Overseeing organizational design and change management, the Drh ensures that the company remains agile in a rapidly changing market. This role involves developing compensation and benefits structures that attract and retain specialized talent in the beauty and health sectors. Yann Dugenou directs internal communication strategies to ensure that all employees remain aligned with the corporate mission. By fostering a collaborative work environment, the Drh enhances cross-functional synergy between the dermo-cosmetic and pharmaceutical teams. The Drh manages labor relations and ensures compliance with international employment regulations. Through the implementation of leadership development programs, the Drh prepares the next generation of managers to lead the company. By prioritizing employee well-being and professional development, the Drh drives organizational performance. Ultimately, the Drh creates a supportive and high-performing workplace that enables the company to achieve its strategic goals in the global dermo-cosmetic market.
Explore Leadership Teams in Manufacturing
Fresenius Kabi, a subsidiary of Fresenius, is a global health care company that specializes in medicines and technologies for infusion, transfusion, and clinical nutrition. Fresenius Kabi is headquartered in Bad Homburg, Germany with locations around the world.
Company Leadership SM
RT

Sarepta Therapeutics, Inc. is a global commercial-stage biopharmaceutical company founded in 1980 and headquartered in Cambridge, Massachusetts. The company is focused on the discovery, development, and commercialization of precision genetic medicines for rare diseases, with particular leadership in Duchenne muscular dystrophy and limb-girdle muscular dystrophies. Sarepta's multi-platform Precision Genetic Medicine Engine spans gene therapy, RNA-targeted therapeutics, and gene editing modalities. The company holds multiple FDA-approved treatments and maintains a broad pipeline of programs across neuromuscular and central nervous system disorders. Sarepta operates globally with locations across North America, Europe, and Asia, and trades on the NASDAQ under the ticker symbol SRPT.
Company Leadership
AN

ZG
Humanetics Corporation is a clinical-stage pharmaceutical company engaged in the accelerated discovery, development, and commercialization of proprietary drugs in markets with urgent and unmet needs with a focus on medical countermeasures, radiation modulators for oncology and inflammatory lung diseases.
Company Leadership BL
KN
SC
AS
Founded in 1994 and headquartered in Shanghai, China, Fosun Pharma is a company that focuses on the research and development and manufacturing of pharmaceuticals.
Company Leadership YB
YS
AH